JPRN-UMIN000013951已完成未知
Phase II study of concurrent chemotherapy with itraconazole in advanced gynecologic tumors. - P2 trial of itraconazole
Department of Obstetrics and Gynecology, Hyogo College of Medicine0 个研究点目标入组 16 人开始时间: 2014年5月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •history of gemecitabine or docetaxel
研究者
相似试验
已完成
1 期
Phase I study of combination chemotherapy with irinotecan hydrochroride(CPT-11) and nedaplatin(NDP) for locally advanced stage Ib2-IVa cervical cancer after Concurrent chemoradiotherapy (CCRT)Stage Ib2-IVa cervical cancerJPRN-UMIN000007458Japanese Gynecologic Oncology Group48
招募中
2 期
Phase II study of combination chemotherapy with TS-1/irinotecan and bevacizumab as second-line therapy in patient with K-RAS mutation-type metastatic colorectal canceradvanced/metastatic colorectal cancerJPRN-UMIN000005900PO FMPC (Future Medicine Promoting Consortium)40
未知
1 期
A Phase I Study of Concurrent Chemotherapy using TS-1 with Involved Field Radiotherapy for Elderly Patients with Non-Small Cell Lung Cancer.on-Small Cell Lung CancerJPRN-UMIN000002162Hiroshima Radiation Oncology Study Group18
已完成
1 期
Phase I-II study of combination chemotherapy with Irinotecan and Gemcitabine for clear cell or mucinous ovarian cancerClear cell or mucinous ovarian cancerJPRN-UMIN000005952Osaka university, faculty of medicine40
已完成
2 期
A phase II study of combination chemotherapy with carboplatin plus S-1 in advanced lung squamous cell carcinomaung cancerJPRN-UMIN000006983Hamamatsu University School of Medicine50